Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Un… (NCT07490106) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer
France493 participantsStarted 2026-04
Plain-language summary
This is a multicenter, national, interventional, cluster-randomized study, "stepped wedge" design. This study includes patients with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer, currently undergoing systemic palliative treatment and hospitalized on an unscheduled basis. The study will aim to evaluate the impact of early palliative care implementation for patients with metastatic or advanced cancer identified during an unplanned hospitalization.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects aged 18 years and older;
* Diagnosed with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer;
* Currently undergoing systemic palliative treatment (no prospect of cure);
* Hospitalized on an unscheduled basis (i.e., unplanned hospitalization for scheduled oncology treatments);
* Patient covered by the French social security system;
* Informed consent, written and signed.
Exclusion Criteria:
* PS (WHO) = 4;
* Patient receiving end-of-life care;
* Patient opposed to the use of medical data for research purposes;
* Person deprived of liberty or under guardianship;
* Inability to undergo medical monitoring for the trial for geographical, social, or psychological reasons.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Aggressiveness of end-of-life care (composite endpoint)
Timeframe: Assessed during the last 30 days of life and up to 14 days before death